A Philadelphia jury has awarded nearly $28 million to the plaintiffs in the first bellwether trial to take place in state court over the blood thinner Xarelto. The verdict comes after three straight losses for plaintiffs in federal court.
*May exclude premium content
Already have an account? Sign In Now
Interested in customizing your subscription with Law.com All Access?
Contact our Sales Professionals at 1-855-808-4530 or send an email to firstname.lastname@example.org to learn more.